-
EP1729776
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1729776
| EP1729776 - PYRROLE DERIVATIVES AS GONADOTROPIN RELEASING HORMONE (GNRH) ANTAGONISTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 13.08.2010 Database last updated on 06.11.2024 | Most recent event Tooltip | 13.08.2010 | Application deemed to be withdrawn | published on 15.09.2010 [2010/37] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [N/P] |
| Former [2006/50] | For all designated states AstraZeneca AB S-151 85 Södertälje / SE | Inventor(s) | 01 /
HARRIS, Craig Steven, AstraZeneca Pharma ZI 1a Pompelle BP 1050 F-51689 Reims Cedex 2 / FR | [2006/50] | Representative(s) | French, Philip Joseph AstraZeneca Global Intellectual Property 151 85 Södertälje / SE | [N/P] |
| Former [2006/50] | French, Philip Joseph Astrazeneca AB, Global Intellectual Property 151 85 Sodertalje / SE | Application number, filing date | 05708368.5 | 17.02.2005 | [2006/50] | WO2005GB00560 | Priority number, date | EP20040290467 | 20.02.2004 Original published format: EP 04290467 | [2006/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005079805 | Date: | 01.09.2005 | Language: | EN | [2005/35] | Type: | A1 Application with search report | No.: | EP1729776 | Date: | 13.12.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.09.2005 takes the place of the publication of the European patent application. | [2006/50] | Search report(s) | International search report - published on: | EP | 01.09.2005 | Classification | IPC: | A61K31/5377, A61K31/4439, A61K31/497, A61K31/4545, A61K31/4535, A61K31/4025, A61K31/40, A61K31/454, A61P5/24, A61P35/00, A61P43/00 | [2006/50] | CPC: |
A61K31/5377 (EP,US);
A61K31/40 (EP,US);
A61K31/4025 (EP,US);
A61K31/4439 (EP,US);
A61K31/4535 (EP,US);
A61K31/454 (EP,US);
A61K31/4545 (EP,US);
A61K31/497 (EP,US);
A61P13/08 (EP);
A61P15/08 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/50] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | LV | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | PYRROL-DERIVATE ALS GNRH-ANTAGONISTEN | [2006/50] | English: | PYRROLE DERIVATIVES AS GONADOTROPIN RELEASING HORMONE (GNRH) ANTAGONISTS | [2006/50] | French: | DERIVES DE PYRROLE UTILISES EN TANT QU'ANTAGONISTES DE L'HORMONE LIBERANT DE LA GONADOTROPHINE (GNRH) | [2006/50] | Entry into regional phase | 20.09.2006 | National basic fee paid | 20.09.2006 | Designation fee(s) paid | 20.09.2006 | Examination fee paid | Examination procedure | 20.09.2006 | Examination requested [2006/50] | 08.05.2007 | Despatch of a communication from the examining division (Time limit: M04) | 11.09.2007 | Reply to a communication from the examining division | 03.04.2008 | Despatch of a communication from the examining division (Time limit: M02) | 22.05.2008 | Reply to a communication from the examining division | 10.11.2009 | Communication of intention to grant the patent | 23.03.2010 | Application deemed to be withdrawn, date of legal effect [2010/37] | 27.04.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2010/37] | Fees paid | Renewal fee | 28.02.2007 | Renewal fee patent year 03 | 29.02.2008 | Renewal fee patent year 04 | 28.03.2008 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 28.02.2010 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO9603383 (LILLY CO ELI [US], et al) [A] 1-18 * abstract * * page 3, line 31 - page 5, line 22 * * claims 1-32 *; | [A]WO9802430 (PFIZER PHARMA [JP], et al) [A] 1-18 * abstract * * page 3, line 25 - page 4, line 2 * * page 24, line 20 - line 29 * * examples 1-95 * * claims 1-22 *; | [A]WO0053185 (MERCK & CO INC [US], et al) [A] 1-18 * abstract * * page 3, line 20 - page 5, line 12 * * example 1 * * claims 1-28 *; | [DPA]WO2004017961 (ASTRAZENECA AB [SE], et al) [DPA] 1-18 * abstract * * page 1, line 1 - line 22 * * examples 1-12 * * claims 1-16 *; | [DPA]WO2004018479 (ASTRAZENECA AB [SE], et al) [DPA] 1-18 * abstract * * page 1, line 1 - line 22 * * examples 1-9 ** claims 1-15 * |